ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
15.04
+0.08 (0.53%)
Jan 17, 2025, 4:00 PM EST - Market closed
ClearPoint Neuro Employees
ClearPoint Neuro had 107 employees as of December 31, 2023. The number of employees decreased by 1 or -0.93% compared to the previous year.
Employees
107
Change (1Y)
-1
Growth (1Y)
-0.93%
Revenue / Employee
$284,383
Profits / Employee
-$169,598
Market Cap
414.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CLPT News
- 2 months ago - ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - Accesswire
- 2 months ago - ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha
- 2 months ago - ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ClearPoint Neuro Reports Third Quarter 2024 Results - Accesswire
- 2 months ago - ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - Accesswire
- 3 months ago - ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - GlobeNewsWire
- 5 months ago - ClearPoint Neuro Announces Early Repayment of $10 Million Note - GlobeNewsWire
- 5 months ago - ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade) - Seeking Alpha